title: Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β-amyloid peptide toxicity.
abstract: Epidemiological studies have reported that coffee and/or caffeine consumption may reduce Alzheimer's disease (AD) risk. We found that coffee extracts can similarly protect against β-amyloid peptide (Aβ) toxicity in a transgenic Caenorhabditis elegans Alzheimer's disease model. The primary protective component(s) in this model is not caffeine, although caffeine by itself can show moderate protection. Coffee exposure did not decrease Aβ transgene expression and did not need to be present during Aβ induction to convey protection, suggesting that coffee exposure protection might act by activating a protective pathway. By screening the effects of coffee on a series of transgenic C. elegans stress reporter strains, we identified activation of the skn-1 (Nrf2 in mammals) transcription factor as a potential mechanism of coffee extract protection. Inactivation of skn-1 genetically or by RNAi strongly blocked the protective effects of coffee extract, indicating that activation of the skn-1 pathway was the primary mechanism of coffee protection. Coffee also protected against toxicity resulting from an aggregating form of green fluorescent protein (GFP) in a skn-1-dependent manner. These results suggest that the reported protective effects of coffee in multiple neurodegenerative diseases may result from a general activation of the Nrf2 phase II detoxification pathway.
authors.affiliation: Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado 80309, USA.
authors.forename: Vishantie
authors.initials: V
authors.lastname: Dostal
authors.forename: Christine M
authors.initials: CM
authors.lastname: Roberts
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Link
mesh_terms: D016229:Amyloid beta-Peptides / Q000737:chemistry / Q000235:genetics / Q000633:toxicity*; D000818:Animals; D017173:Caenorhabditis elegans / Q000187:drug effects* / Q000235:genetics*; D029742:Caenorhabditis elegans Proteins / Q000378:metabolism; D002110:Caffeine / Q000494:pharmacology / Q000627:therapeutic use; D031204:Caloric Restriction; D004268:DNA-Binding Proteins / Q000378:metabolism; D005247:Feeding Behavior / Q000187:drug effects; D049452:Green Fluorescent Proteins / Q000378:metabolism; D023421:Models, Animal; D009068:Movement / Q000187:drug effects; D009154:Mutation / Q000235:genetics; D010243:Paralysis / Q000188:drug therapy / Q000503:physiopathology; D010936:Plant Extracts / Q000494:pharmacology* / Q000627:therapeutic use; D020836:Protein Structure, Quaternary; D014157:Transcription Factors / Q000378:metabolism; D019076:Transgenes / Q000235:genetics
chemical_list: D016229:Amyloid beta-Peptides; D029742:Caenorhabditis elegans Proteins; D004268:DNA-Binding Proteins; D010936:Plant Extracts; D014157:Transcription Factors; D049452:Green Fluorescent Proteins; C073702:skn-1 protein, C elegans; D002110:Caffeine
references.citation: Methods Enzymol. 2002;353:497-505
references.pmid: 12078522
references.citation: Arch Biochem Biophys. 2008 Aug 15;476(2):171-7
references.pmid: 18424257
references.citation: J Alzheimers Dis. 2009;17(3):661-80
references.pmid: 19581722
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16505-10
references.pmid: 19805328
references.citation: J Neurosci. 2010 Apr 21;30(16):5525-32
references.pmid: 20410106
references.citation: BMC Mol Biol. 2008 Jan 22;9:9
references.pmid: 18211699
references.citation: Mov Disord. 2007 Nov 15;22(15):2242-8
references.pmid: 17712848
references.citation: J Neurosci. 2008 Jan 9;28(2):465-72
references.pmid: 18184789
references.citation: Genetics. 1995 Dec;141(4):1365-82
references.pmid: 8601480
references.citation: J Biol Chem. 2006 Jan 20;281(3):1808-16
references.pmid: 16239215
references.citation: Cell Stress Chaperones. 1999 Dec;4(4):235-42
references.pmid: 10590837
references.citation: Nature. 1991 Oct 31;353(6347):844-6
references.pmid: 1944558
references.citation: Science. 1991 Oct 4;254(5028):97-9
references.pmid: 1925564
references.citation: Neurobiol Aging. 2003 May-Jun;24(3):397-413
references.pmid: 12600716
references.citation: J Biol Chem. 2010 Mar 12;285(11):8171-84
references.pmid: 20068043
references.citation: J Biol Chem. 2008 Jan 11;283(2):784-91
references.pmid: 17993648
references.citation: Genes Dev. 2003 Aug 1;17(15):1882-93
references.pmid: 12869585
references.citation: Aging Cell. 2009 Jun;8(3):258-69
references.pmid: 19627265
references.citation: Nat Cell Biol. 2000 Dec;2(12):931-7
references.pmid: 11146658
references.citation: J Neurosci. 2008 Dec 10;28(50):13574-81
references.pmid: 19074031
references.citation: Free Radic Biol Med. 2007 Dec 1;43(11):1560-6
references.pmid: 17964427
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2933-8
references.pmid: 19196989
references.citation: Mech Ageing Dev. 2010 Feb;131(2):105-10
references.pmid: 20064547
references.citation: Cell. 1992 Mar 20;68(6):1061-75
references.pmid: 1547503
references.citation: Autophagy. 2007 Nov-Dec;3(6):569-80
references.pmid: 17675890
references.citation: Biochem Biophys Res Commun. 2009 Sep 11;387(1):109-14
references.pmid: 19576171
references.citation: Toxicol Appl Pharmacol. 2008 Feb 1;226(3):328-37
references.pmid: 18028974
references.citation: Mol Pharmacol. 2008 Jun;73(6):1785-95
references.pmid: 18334601
references.citation: Hum Mol Genet. 1996;5 Spec No:1449-55
references.pmid: 8875251
references.citation: Nature. 2003 Jan 16;421(6920):231-7
references.pmid: 12529635
references.citation: Mol Cell Neurosci. 2008 Nov;39(3):302-13
references.pmid: 18706502
references.citation: Nature. 2007 May 31;447(7144):545-9
references.pmid: 17538612
references.citation: Aging Cell. 2008 Jun;7(3):394-404
references.pmid: 18331616
references.citation: Curr Biol. 2001 Dec 11;11(24):1975-80
references.pmid: 11747825
references.citation: Neurobiol Aging. 2001 Mar-Apr;22(2):217-26
references.pmid: 11182471
references.citation: Biochem J. 2008 Jan 1;409(1):205-13
references.pmid: 17714076
references.citation: Genes Dev. 2001 Oct 1;15(19):2562-71
references.pmid: 11581161
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6334-9
references.pmid: 11972038
references.citation: FASEB J. 2010 Feb;24(2):383-92
references.pmid: 19783783
references.citation: Sci Signal. 2010 Mar 09;3(112):re3
references.pmid: 20215646
references.citation: Arch Pharm Res. 2009 Jan;32(1):109-15
references.pmid: 19183883
references.citation: Mol Nutr Food Res. 2010 Jul;54(7):956-66
references.pmid: 20166143
references.citation: Hum Mol Genet. 2009 Aug 1;18(15):2739-47
references.pmid: 19414486
references.citation: Nature. 2002 Jan 3;415(6867):92-6
references.pmid: 11780124
references.citation: Mutat Res. 2008 Jul-Aug;659(1-2):31-9
references.pmid: 18164232
references.citation: Neurol Res. 2007 Jan;29(1):91-5
references.pmid: 17427282
references.citation: Oncogene. 2009 Nov 12;28(45):3983-96
references.pmid: 19734940